Bri-Chem Corp.
Bri-Chem Corp. (BRY.TO) Financial Performance & Income Statement Overview
Explore the financials of Bri-Chem Corp. (BRY.TO), including yearly and quarterly data on income, cash flow, and balance sheets.
Bri-Chem Corp. (BRY.TO) Income Statement & Financial Overview
View the income breakdown for Bri-Chem Corp. BRY.TO across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $19.91M | $20.62M | $21.98M | $19.11M |
| Cost of Revenue | $16.47M | $17.91M | $18.16M | $17.20M |
| Gross Profit | $3.44M | $2.71M | $3.82M | $1.90M |
| Gross Profit Ratio | $0.17 | $0.13 | $0.17 | $0.10 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $2.99M | $2.02M | $3.28M | $1.28M |
| Operating Expenses | $3.32M | $2.33M | $3.58M | $1.28M |
| Total Costs & Expenses | $19.79M | $20.24M | $21.74M | $18.49M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $725863.00 | $703644.00 | $787982.00 | $896945.00 |
| Depreciation & Amortization | $327500.00 | $313307.00 | $307310.00 | $325367.00 |
| EBITDA | $466618.00 | -$1.17M | $587164.00 | $706827.00 |
| EBITDA Ratio | $0.02 | -$0.06 | $0.03 | $0.04 |
| Operating Income | $121088.00 | $380452.00 | $233835.00 | $620160.00 |
| Operating Income Ratio | $0.006 | $0.02 | $0.01 | $0.03 |
| Other Income/Expenses (Net) | -$707833.00 | -$2.57M | -$741963.00 | -$1.14M |
| Income Before Tax | -$586745.00 | -$2.19M | -$508128.00 | -$515481.00 |
| Income Before Tax Ratio | -$0.03 | -$0.11 | -$0.02 | -$0.03 |
| Income Tax Expense | -$174965.00 | -$602374.00 | -$239301.00 | -$27680.00 |
| Net Income | -$411780.00 | -$1.59M | -$268827.00 | -$487801.00 |
| Net Income Ratio | -$0.02 | -$0.08 | -$0.01 | -$0.03 |
| EPS | -$0.02 | -$0.06 | -$0.01 | -$0.02 |
| Diluted EPS | -$0.02 | -$0.06 | -$0.01 | -$0.02 |
| Weighted Avg Shares Outstanding | $26.43M | $26.43M | $26.88M | $26.43M |
| Weighted Avg Shares Outstanding (Diluted) | $26.53M | $26.43M | $26.88M | $26.43M |
The company's financials show resilient growth, with revenue advancing from $19.11M in Q2 2024 to $19.91M in Q1 2025. Gross profit remained healthy with margins at 17% in Q1 2025 compared to 10% in Q2 2024. Operating income hit $121088.00 last quarter, sustaining a consistent 1% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $466618.00. Net income rose to -$411780.00, while earnings per share reached -$0.02. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan